Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. - Wikidata - awgldk - TriplyDB

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

http://www.wikidata.org/entity/Q37405449

about

Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation Quantification of liver fibrosis in chronic hepatitis B virus infection.Assessment of liver fibrosis using fast strain-encoded MRI driven by inherent cardiac motion.Non-invasive diagnosis of advanced fibrosis and cirrhosis.Can NASH be diagnosed, graded, and staged noninvasively?Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease Histopathology of nonalcoholic fatty liver disease.The influence of dietary fat on liver fat accumulation.Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology.Metabolic syndrome and hepatic resection: improving outcome Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease.Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients.Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease.Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis What is critical for liver surgery and partial liver transplantation: size or quality?Quantification of liver fat with magnetic resonance imaging.Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.ASH and NASH.Latest developments in the imaging of fibrotic liver disease.Endoscopic ultrasound-guided liver biopsy.Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Histological Assessment of NAFLD.Non-invasive diagnosis of hepatic steatosis.Pathology of non-alcoholic fatty liver disease.Myths and mysteries about staging hepatic fibrosis by fibroscan.Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis.Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.Multiparametric functional magnetic resonance imaging for evaluation of hepatic warm ischemia-reperfusion injury in a rabbit model.Improved liver R2* mapping by pixel-wise curve fitting with adaptive neighborhood regularization.Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH.Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model.Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame.Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

P2860

Q26771722-0156E8FB-75AB-4F81-AE21-E370408810D7 Q26782440-A9EAF372-556F-424E-B579-3A58401CBA43 Q30392447-3EC9A7DD-82FB-4B27-BAAD-ED7CCD5E03A3 Q30423320-6D1F5ECB-63BE-40FF-9503-3B233A339A21 Q30451362-5E8512D6-1497-4E90-93ED-0AF8615968BB Q30478139-B20D5444-675F-4780-9726-65D95E972AF1 Q34185231-A08BA74A-2534-44DD-96FA-C9EDD514D775 Q34297858-B6F25735-2DBB-45D7-9578-CA7FA3DF7B17 Q34306736-1AF49B12-7960-4174-99F9-64A7CD1F89DA Q34578071-8B82EB2D-1C9B-40EA-8CBF-2110124A6109 Q34764818-9BDABEE4-A00D-43FC-A4AD-CE9F04D8EBBF Q35629684-F99114E6-B02B-4362-B7A8-FE3DA134CA8F Q36047930-96A98F2E-ABB7-42DF-AC50-73E1E3D14F40 Q36749997-E7BC09A7-A031-4FF5-A4F0-7A95187D1BD9 Q37157810-9FDF1D17-3164-4001-8FCB-EB39AB5CA416 Q37581357-E290FCF6-3357-420B-9284-9CC6AD2908C1 Q37777694-136F1C89-45BB-4C49-8396-B4116B7B979E Q37811338-4D69A248-F6DB-4C87-AF74-0B019CDFB761 Q37863136-338BDC12-5A0C-4148-9FBB-84CAB268D85C Q37898415-77A73031-F778-48C0-8F2C-3EF70791E256 Q38162372-47B25075-1D95-4BFC-8EC0-2F873B96C91D Q38505618-50FAA1A3-4E87-4114-8F18-4D71890BFADA Q38607460-0D25CBCE-DCD6-488D-8CFE-E5E3E4366B7E Q38676257-5C1867C3-51F4-4059-B479-C7F72E9494ED Q38732493-A0A6B6D4-2A7A-4C0F-99A7-5A8C8A554694 Q38991269-E4EFD5C3-6940-4D43-B1DF-7768CDF9074C Q39067346-87037677-938F-41FD-A971-353067008FF7 Q42736140-93726EE6-717D-45C2-8143-5E69F60EC2A6 Q43815610-4C41D198-DE20-497F-A62F-83968F3B48DC Q43960965-1CC976C6-DF50-4333-AFFD-8AFEE0C1E672 Q44227516-348769BA-53DA-446E-8D40-864422CB7BFE Q45325816-926985F8-5862-408C-AD37-736F27E3D6DB Q46628692-AA5679F9-B65E-440E-8C2C-653644327899 Q47147514-44DB5298-E40C-4500-AA7E-132183FCCCB3 Q47563378-0B7B2ECE-1933-4C61-BF57-F8520B2D03CD Q48092326-DBD79346-1807-4357-A0E3-C6FF75E60A0E Q51014101-EA0C4603-AF78-47AF-993D-EA511D6EB47B Q53306497-E93F7CC8-171A-4259-BC5F-056284C96952 Q53570137-E8D1AA7E-ECC9-4BB0-896F-045A2B4A0FD2 Q58549444-94EEF08C-6697-4997-8593-6F0E0A4CCC23

P2860

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

http://www.wikidata.org/entity/Q37405449

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of liver biopsy sample ...... alcoholic Fatty liver disease.

@en

Effects of liver biopsy sample ...... alcoholic Fatty liver disease.

@nl

type

label

Effects of liver biopsy sample ...... alcoholic Fatty liver disease.

@en

Effects of liver biopsy sample ...... alcoholic Fatty liver disease.

@nl

prefLabel

Effects of liver biopsy sample ...... alcoholic Fatty liver disease.

@en

Effects of liver biopsy sample ...... alcoholic Fatty liver disease.

@nl

P1433

Q37405449-E57D11F9-71CE-49CB-AE8E-B8F3AB0742B2

P1476

Q37405449-6551881E-3924-496D-AED0-10C044FF05C0

P2093

Q37405449-022D539E-3A85-470B-A797-3CD3518AF5F7

Q37405449-060C3F33-E05E-40BA-960D-E736BD91EE01

Q37405449-3F62F829-B459-4A13-8D2B-C3A00E359D9F

Q37405449-490AF598-E355-4902-923C-31CC9EE4D54F

Q37405449-6D9E6EC3-DD08-4661-9D0E-F1AD082A7B07

Q37405449-711D72F8-572A-4F56-979A-D931B6F45F4F

Q37405449-80412CC0-A329-4453-96D7-47088B667140

P2860

Q37405449-2FAE1FF9-B0FC-4C64-9615-182BB8D2BEF8

Q37405449-32406D12-023C-4FA0-A6D1-61238B361CC5

Q37405449-41ED3B09-7DA0-480C-8105-BE07DF52EE15

Q37405449-7EFBD29D-F2E4-4805-AAF5-61A6BD81F55C

Q37405449-84B5E265-CF8A-4738-B14F-29962BD13844

Q37405449-8555A746-D204-4373-B5BB-933283D6596C

Q37405449-886ACBBE-C794-4DFF-ADEA-6D04C119423F

Q37405449-8EBC8ADE-7AAF-4DAF-BD8A-5DE01B21B686

Q37405449-900A9FE8-5913-4FBD-A6C1-EC9129983B3D

Q37405449-903DD539-2C6D-4E14-BC48-2CF9303972AA

P304

Q37405449-C7DAB7F4-67B9-419F-BFCE-4D4C739DCC70

P31

Q37405449-2D8D2DBA-4856-48D3-AA6F-B2041E305E79

P356

Q37405449-245AFBAB-AC8A-4E7B-A5C4-DDF7FFC3A919

P407

Q37405449-A970199F-1B1C-45B0-8311-1FB19D80EB87

P433

Q37405449-5D3FB726-1283-41E8-8D6C-E4338D467A24

P478

Q37405449-4FD7678F-9357-44F9-9D79-66F89D91AD8D

P50

Q37405449-5DAB840B-40D7-468A-8C18-E63116B7ABC1

P577

Q37405449-7F54C350-B425-43BD-A89A-9C84F170746C

P5875

Q37405449-C50D2D4E-71F0-4034-984F-1152D7130548

P698

Q37405449-B0E5B2E8-E05B-4CC6-8E26-2B44EACC37BD

P921

Q37405449-028B0A92-72A6-4A07-8DC3-6CA522D3FCC2

P932

Q37405449-061423C7-CA3E-4481-9412-4F844BE17E11

P356

J.CGH.2008.12.015

P1433

Clinical Gastroenterology and Hepatology

P1476

Effects of liver biopsy sample ...... nalcoholic Fatty liver disease

@en

P2093

Aynur Unalp

http://www.w3.org/2001/XMLSchema#string

James Tonascia

http://www.w3.org/2001/XMLSchema#string

Kumar E Sandrasegaran

http://www.w3.org/2001/XMLSchema#string

Mark L Van Natta

http://www.w3.org/2001/XMLSchema#string

Naga Chalasani

http://www.w3.org/2001/XMLSchema#string

Oscar W Cummings

http://www.w3.org/2001/XMLSchema#string

Tariq Hameed

http://www.w3.org/2001/XMLSchema#string

P2860

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

A systematic review of the quality of liver biopsy specimens.

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

P304

481-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2008.12.015

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Raj Vuppalanchi

P577

2008-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23931403

http://www.w3.org/2001/XMLSchema#string

P698

19162235

http://www.w3.org/2001/XMLSchema#string

P921

P932

2770348

http://www.w3.org/2001/XMLSchema#string